Results 191 to 200 of about 29,631 (205)
Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature. [PDF]
Chandrasekaran S +7 more
europepmc +1 more source
Humoral and functional SARS-CoV-2-specific T-cell responses elicited in chronic lymphocytic leukaemia patients with GEO-CM04S1 a synthetic MVA-vectored COVID-19 vaccine. [PDF]
Ortega-Francisco S +24 more
europepmc +1 more source
Evaluation of vaccine-induced antibody responses against SARS-CoV-2 in multiple myeloma patients from the northeastern region of Mexico. [PDF]
Salazar-Riojas R +6 more
europepmc +1 more source
Acute Kidney Injury Following Vaccine-Induced Thrombotic Microangiopathy. [PDF]
Aabideen M, Vellanki VS, Tungekar MF.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Decreased Infectivity Following BNT162b2 Vaccination
SSRN Electronic Journal, 2021Background: BNT162b2 was shown to be 92% effective in preventing COVID-19. Prioritizing vaccine rollout, and achievement of herd immunity depend on SARS-CoV-2 transmission reduction. The vaccine’s effect on infectivity is thus a critical priority. Methods: In a cohort of all 9650 HCW of a large single tertiary medical center, we calculated the ...
Gili Regev-Yochay +16 more
openaire +1 more source
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents
Pediatrics, 2023OBJECTIVES We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the Omicron BA.4/BA.5 period. METHODS Using VISION Network records from April 2021
Nicola P, Klein +45 more
openaire +2 more sources
Cellular Immunology
Several vaccines targeting SARS-CoV-2 were developed following the COVID-19 outbreak. However, subsequent studies have indicated that humoral immune responses wane over time, particularly with the emergence of new SARS-CoV-2 variants. There is limited understanding of the resilience of T cell-mediated immunity induced by COVID-19 vaccines.
Mat Jusoh, Siti Asmaa +10 more
openaire +2 more sources
Several vaccines targeting SARS-CoV-2 were developed following the COVID-19 outbreak. However, subsequent studies have indicated that humoral immune responses wane over time, particularly with the emergence of new SARS-CoV-2 variants. There is limited understanding of the resilience of T cell-mediated immunity induced by COVID-19 vaccines.
Mat Jusoh, Siti Asmaa +10 more
openaire +2 more sources

